Un nuevo brazo robótico protésico de bajo coste se perfila como una buena alternativa a las prótesis convencionales del mercado y a otros brazos robóticos protésicos mucho más caros. El equipo de ingeniería biomédica ARM2u, de la Escue …
La calidad y la seguridad de los productos y equipos son fundamentales para cualquier empresa que busque destacar en unos mercados cada vez más competitivos. Por esta razón, resulta de vital importancia realizar pruebas exhaustivas que garanticen que todo se encuentra en orde …
Pruebas FAT en proyectos industriales, ¿qué son y para qué sirven? Read More »
La explosión de tipo supernova de una estrella es un acontecimiento espectacular, pero los restos que deja la catástrofe pueden ser aún más espectaculares. Una nueva imagen captada en la banda del infrarrojo medio por el telescopio espacial James Webb ofrece un e …
Detalles nunca antes vistos en Casiopea A, donde explotó una estrella Read More »
Los artefactos de piedra, huesos o dientes proporcionan información importante sobre las estrategias de subsistencia de los primeros humanos, su comportamiento y su cultura. Sin embargo, hasta ahora ha sido difícil atribuir estos artefactos a individuos concretos, ya que los enterramie …
Obtienen de un pendiente el ADN de la mujer que lo llevó hace unos 20.000 años Read More »
Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology, its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Technology Park.
Zynex, Inc., announced the pricing of its previously announced private offering of $52.5 million aggregate principal amount of 5.00% convertible senior notes due 2026 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering Read More »
Formosa Pharmaceuticals, Inc. and AimMax Therapeutics, Inc. announce the submission of a New Drug Application to the United States Food & Drug Administration for APP13007, a novel aqueous nanosuspension formulation of the potent corticosteroid, clobetasol propionate, for the treatment of inflammation and pain following ocular surgery.
CANbridge Pharmaceuticals, Inc., a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, announced that it has appointed Jason West, Ph.D., to the position of Vice President, Head of Gene Therapy Research, effective immediately.
CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.
SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the pricing of its underwritten public offering of 3,775,000 shares of its common stock at a price to the public of $22.00.
SI-BONE Announces Pricing of Public Offering of Common Stock – May 05, 2023 Read More »
